NEW HEALTH SCIENCES, INC.
Bethesda, MD · Medtech · Private
Additive solution for red blood cell storage under hypoxic conditions to minimize storage-associated damage
- Grants
- $8.5M
- 7 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $1.7M
- 1 award · Health and Human S
- #245 of 4531 in medtech
- Patents
- 40
- 10 granted · 30 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20122014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Igf::ot::igf Develop A Novel, Low Cost, Blood Storage System That Will Deliver Red Cells Of Higher Quality, Thereby Reducing The Harmful Consequences Of Transfusion Therapy. Hasp Is Designed For Maximum Ease-of-integration Into Existing Blood Bank Operating Practices With Minimal Alteration In Procedures, Equipment Or Cost. | $1,660,011 | |
| Federal grant | Department of Health and Human Services · Phase II · Regulatory Approval & Commercialization of an RBC Processing and Storage System to Improve Transfusion Therapy by Minimizing Oxidative Damage to RBC during Storage | $2,969,757 | |
| Federal grant | Department of Health and Human Services · Phase II · Regulatory Approval & Commercialization of an RBC Processing and Storage System to Improve Transfusion Therapy by Minimizing Oxidative Damage to RBC during Storage | $997,658 | |
| Federal grant | Department of Health and Human Services · Phase II · Regulatory Approval & Commercialization of an RBC Processing and Storage System to Improve Transfusion Therapy by Minimizing Oxidative Damage to RBC during Storage | $980,623 | |
| Federal grant | Department of Health and Human Services · Phase II · An additive solution optimized for anaerobic (hypoxic) RBC storage to minimize storage lesion development. | $1,495,034 | |
| Federal grant | Department of Health and Human Services · Phase II · An additive solution optimized for anaerobic (hypoxic) RBC storage to minimize storage lesion development. | $773,178 | |
| Federal grant | Department of Health and Human Services · Phase I · Hypoxically stored whole blood--evaluation of platelet activities under hypoxic storage conditions | $295,963 | |
| Federal grant | Department of Health and Human Services · Phase II · Efficacy of Hypoxic Red Blood Cells Processed with the Hemanext ONE® System in Patients with Sickle Cell Anemia | $1,017,232 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 242 | DIAPEDIA, LLC | $1.7M | — |
| 243 | Evoke Neuroscience, Inc. | $1.7M | — |
| 244 | INFRAREDX INC | $1.7M | $57M |
| 245 | NEW HEALTH SCIENCES, INC. | $1.7M | — |
| 246 | ALA SCIENTIFIC INSTRUMENTS INC | $1.6M | — |
| 247 | GLUCOSENTIENT INC | $1.6M | $60K |
| 248 | IMAGINAB, INC. | $1.6M | $36M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- System For Extended Storage Of Red Blood Cells And Methods Of Usegranted
- Anaerobic Blood Storage and Pathogen Inactivation Methodgranted
- Integrated Leukocyte, Oxygen And/or CO2 Depletion, And Plasma Separation Filter Devicegranted
- Oxygen Reduction Disposable Kits, Devices And Methods Of Use Thereofgranted
- Method And System For Removing Oxygen And Carbon Dioxide During Red Cell Blood Processing Using An Inert Carrier Gas And Manifold Assemblygranted
- Gas Depletion And Gas Addition Devices For Blood Treatmentgranted
- System for Extended Storage of Red Blood Cells and Methods of Usegranted
- Anaerobic Blood Storage Containersgranted
- Integrated Leukocyte, Oxygen And/or CO2 Depletion, And Plasma Separation Filter Devicegranted
- Blood Storage Bag System And Depletion Devices With Oxygen And Carbon Dioxide Depletion Capabilitiesapplication
- Blood Storage Bag System And Depletion Devices With Oxygen And Carbon Dioxide Depletion Capabilitiesgranted
- Methods for Managing Adverse Events in Patient Populations Requiring Transfusionapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.